ArticleStudies in mycology2019
Foliar pathogens of eucalypts.
Article in Studies in mycology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed.
- Massive proliferation of retrotransposons contributes to genome size expansion in species of the Pseudocercospora genus.Mobile DNA · 2026Article
- Three new species ofMycoKeys · 2026Article
- Fungal Communities in Asymptomatic and Symptomatic Needles ofMicroorganisms · 2025Article
- Genera of phytopathogenic fungi known from culture: 1-379.Studies in mycology · 2025Article
- Transcriptional responses of Eucalyptus to infection by an aggressive leaf blight pathogen reveal the role of host secondary metabolites during pathogen germination.Plant molecular biology · 2025Article
- Article
- Insight into the composition and differentiation of endophytic microbial communities in kernels via 368 maize transcriptomes.Journal of advanced research · 2025Article
- Novel endophytic fungi from Pinus: introducing three new genera and six new species withinIMA fungus · 2025Article
- Addition of two new genera-Frontiers in cellular and infection microbiology · 2025Article
- Meristematic and meristematic-like fungi inFungal systematics and evolution · 2024Article
- Article
- Filamentous Fungi Associated with Disease Symptoms in Non-Native Giant Sequoia (Pathogens (Basel, Switzerland) · 2024Article
- What are the 100 most cited fungal genera?Studies in mycology · 2024Article
- Species diversity inFungal systematics and evolution · 2024Article
- Fungal Planet description sheets: 1614-1696.Fungal systematics and evolution · 2024Article
- Article
- Diversity of Rock-Inhabiting Fungi in Tarragona Province, Spain.Journal of fungi (Basel, Switzerland) · 2024Article
- Wide Distribution ofMicroorganisms · 2024Article
- Palm Fungi and Their Key Role in Biodiversity Surveys: A Review.Journal of fungi (Basel, Switzerland) · 2023Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Species of eucalypts are commonly cultivated for solid wood and pulp products. The expansion of commercially managed eucalypt plantations has chiefly been driven by their rapid growth and suitability for propagation across a very wide variety of sites and climatic conditions. Infection of foliar fungal pathogens of eucalypts is resulting in increasingly negative impacts on commercial forest industries globally. To assist in evaluating this threat, the present study provides a global perspective on foliar pathogens of eucalypts. We treat 110 different genera including species associated with foliar disease symptoms of these hosts. The vast majority of these fungi have been grown in axenic culture, and subjected to DNA sequence analysis, resolving their phylogeny. During the course of this study several new genera and species were encountered, and these are described. New genera include:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.